HOVR Prices $20M Common Share Offering, Amplifying Dilution Amid Pre-Revenue Stage

What happened

New Horizon Aircraft has priced a $20 million offering of 9.25 million common shares to institutional investors, adding to the already active ATM program that had $33.4 million remaining as of February 2026. This fixed offering, if completed at or near the current market price, would dilute existing shareholders by roughly 20%, consistent with the company's pattern of funding development through equity sales. The proceeds extend the cash runway beyond the prior 12-month guidance from the February 2026 balance sheet, but the cost is a further reduction in per-share upside potential. While the offering buys time for the Cavorite X7 program to reach its 2027 flight-test target, it does not address the underlying dependency on dilutive capital or the lack of non-dilutive funding scaling. The announcement reinforces the base-case thesis that HOVR will rely on equity issuance to bridge to milestones, with no change to the fundamental schedule or certification risks.

Implication

The $20M offering provides 6-9 months of additional runway, but it increases the per-share value needed to achieve a positive return. Investors must now rely on flight-test milestones in 2027 to overcome the higher share count, raising the bar for valuation appreciation. The lack of alternative funding sources reinforces the bear-case tail risk of persistent dilution.

Thesis delta

This offering materially increases the probability of the base-case dilution scenario outlined in the DeepValue report, where equity sales fund operations without corresponding milestone de-risking. The absence of concurrent non-dilutive funding announcements shifts the risk-reward toward the bear case, where high-frequency ATM issuance at low prices becomes the default funding mechanism. The update does not change the WAIT rating but tightens the attractiveness entry point, as additional shares reduce the per-share value of any future upside.